| Gene Name | ORF Name | Function GO Term | Process GO Term | Component GO Term | Interacting Genes | Description | Gene Product | Phenotype |
| KEM1 | YGL173C | recombinase activity* | 35S primary transcript processing* | cytoplasm* | YCR077C YDR378C YJL124C YHR170W YBL026W YLR398C YJR022W YGL213C YLR438C-A YER112W YER146W YNL147W YOL149W YER016W YLR039C YLR418C YCL029C YGL216W YPR141C YPR135W YHR191C YCL016C YLR200W YGR078C YML094W YLR103C YDR052C YML032C YJR057W | Plays a role in cytoplasmic mRNA degradation. The disparate functions of Kem1p may belie a functiona | 5'-3' exonuclease | Kar1-1 nuclear-fusion-defect Enhancing Mutation. Null mutant grows poorly. muta |
| KEX1 | YGL203C | carboxypeptidase D activity | protein processing | Golgi trans face | YNL322C | Killer toxin and alpha factor precursor processing. Kex1p can cleave lys and arg residues from the C | protease|similar to carboxypeptidase B | Null mutant is viable and defective in killer expression |
| KEX2 | YNL238W | serine-type endopeptidase activity | peptide pheromone maturation | Golgi trans face | YJR053W YLL040C YKL190W YLR039C YBR164C YNL322C | prohormone processing; golgi localization marker, dispensable for meiotic recombination but partiall | Ca2+-dependent serine protease | Null mutant is viable and defective in killer expression |
| KGD1 | YIL125W | oxoglutarate dehydrogenase (lipoamide) activity | tricarboxylic acid cycle* | mitochondrial matrix | YDR148C YFL018C YPL213W YFR049W YHR196W YDL147W YBR217W YMR235C YOR005C YFR016C YML064C YCR079W YHR169W | alpha-ketoglutarate dehydrogenase | alpha-ketoglutarate dehydrogenase | Null mutant is viable but is deficient in alpha-ketoglutarate dehydrogenase, is therefore respirator |
| KGD2 | YDR148C | molecular_function unknown | tricarboxylic acid cycle* | mitochondrial matrix | YFL018C YDR510W YMR012W YER110C YLR180W YFR049W YIL125W YDL239C YHR114W YKL010C YLR423C YMR047C YNL092W YNL189W YPL070W YDL225W YDR388W YMR308C | dihydrolipoyl transsuccinylase component of alpha-ketoglutarate dehydrogenase complex in mitochondri | alpha-ketoglutarate dehydrogenase complex dihydrolipoyl transsuccinylase component | Null mutant is viable but is respiratory deficient (pet-), and its mitochondria are unable to cataly |
| KHA1 | YJL094C | potassium:hydrogen antiporter activity | monovalent inorganic cation transport | membrane | YLR193C | putative K+/H+ antiporter | | |
| KIN1 | YDR122W | protein kinase activity | biological_process unknown | membrane fraction | YOL082W YNL035C YPR120C | Serine/threonine protein kinase | | Null mutant is viable and shows no obvious phenotypes |
| KIN2 | YLR096W | protein kinase activity | biological_process unknown | membrane fraction | YPR159W YGR047C YKL081W YNR052C YHR044C YML057W YKL210W YLL026W YHR158C YAR014C YGR238C YML006C YHR030C | Serine/threonine protein kinase | | |
| KIN28 | YDL108W | general RNA polymerase II transcription factor activity* | protein amino acid phosphorylation* | transcription factor TFIIH complex | YOR151C YDL140C YGL134W YPR025C YOR299W YER171W | serine-threonine kinase, subunit of transcription factor TFIIK, a subcomplex of TFIIH | | Null mutant is inviable |
| KIN4 | YOR233W | protein kinase activity | biological_process unknown | cytoplasm | YPL269W | protein kinase | protein kinase | Null mutant is viable |
| KIP1 | YBL063W | structural constituent of cytoskeleton* | microtubule nucleation* | spindle pole body* | YIL061C YPR141C YEL061C | Mitotic spindle assembly | kinesin related protein | Null mutant is viable; kip1 cin8 double deletion mutants are inviable |
| KIP2 | YPL155C | microtubule motor activity | nuclear migration (sensu Saccharomyces)* | cytoplasmic microtubule* | YGL127C YLR200W YNL153C YEL003W YEL061C YGR078C YML094W YOR349W YER007W YML124C YPL241C YGR092W YAL026C YER016W YOR058C YPL269W YOR326W | kinesin-related protein | kinesin related protein | Null mutant is viable |
| KIP3 | YGL216W | microtubule motor activity | mitotic spindle assembly (sensu Saccharomyces)* | cytoplasmic microtubule* | YDR149C YGL152C YLL049W YER016W YPR141C YKR054C YPR135W YGL173C YOR195W YHR191C YCL016C YMR078C YBL031W YGL174W YHR183W YDR162C YHR129C YMR294W YPL174C YDR424C YDR488C YMR299C YOR269W YDR150W | Kinesin-related protein | | defective in pre-anaphase nuclear migration |
| KNH1 | YDL049C | molecular_function unknown | beta-1,6 glucan biosynthesis | cell wall (sensu Fungi)* | YBR226C YDL033C YDR249C YGR064W YGR206W YHL005C YHR034C YLR282C YNL171C YPR197C YLR330W YJL154C YML071C YOR069W YOR070C YJL148W YKL032C YDL065C YJL174W YDL020C YLR350W YAL002W YGL043W YNL329C YGR135W YMR060C YIL121W YHR013C YGR133W YKL126W YLR360W YG | 46% identical at amino acid level to Kre9p; located extracellularly | KRE9 homolog | Null mutant is viable; overexpression suppresses kre9 mutation; knh1 kre9 double mutant is inviable |
| KRE1 | YNL322C | structural constituent of cell wall | cell wall organization and biogenesis | cell wall (sensu Fungi) | YAL053W YAL056C-A YBL083C YDR129C YCR044C YHR030C YOR035C YER165W YBR023C YBL061C YLR330W YER155C YJR118C YJL183W YJR117W YDL006W YDR162C YKR020W YNL238W YER044C YDR389W YMR238W YBR229C YFR019W YAL026C YPL065W YGL084C YGL168W YKL190W YJR073C YMR060C | cell wall beta-glucan assembly | | Null mutant is viable, exhibits reduction in cell wall (1--6)-beta-glucan |
| KRE11 | YGR166W | molecular_function unknown | ER to Golgi transport | TRAPP | YEL048C YNL171C YOR115C YMR089C YCR044C YJL095W YNL322C YJR118C YMR116C YKR020W YGR229C YLR373C YPL069C YDR407C YMR218C YBR254C YDR246W YDR472W YJL174W YGL084C YDR440W YKL139W YBL101C YNL329C YBR057C YKL041W YMR060C YOR312C YJL176C YGR157W YHR013C YO | Involved in biosynthetic pathway for cell wall beta-glucans | | Null mutant is viable; killer toxin resistant; reduced levels of 1,6-beta-glucan in cell wall |
| KRE2 | YDR483W | alpha-1,2-mannosyltransferase activity | O-linked glycosylation* | Golgi apparatus | YER081W | N-glycosylation | alpha-1,2-mannosyltransferase | have altered N-linked glycosylation of proteins and grow slowly at 30 degrees; unable to grow at 37 |
| KRE5 | YOR336W | UDP-glucose:glycoprotein glucosyltransferase activity | beta-1,6 glucan biosynthesis | endoplasmic reticulum | YER022W | appears to function early in (1,6)-beta-D-glucan synthesis pathway | | Null mutant is viable but has aberrant morphology, reduced levels of cell wall (1,6)-beta-glucan, an |
| KRE6 | YPR159W | glucosidase activity | cell wall organization and biogenesis* | integral to membrane* | YBL053W YBR042C YDL206W YDR248C YEL047C YGL081W YGL196W YFL036W YOR080W YDR137W YGR105W YOR068C YGL244W YML115C YAL055W YGL200C YLL043W YPL192C YKL041W YJL176C YDR385W YIL052C YDR233C YGL135W YKL120W YDR358W YGL215W YLR018C YLR131C YLR165C YKL190W YD | cell wall beta-glucan assembly | beta-glucan synthase (putative) | Null mutant is viable, slow growing, killer toxin-resistant, possesses half the normal level of wild |
| KRI1 | YNL308C | molecular_function unknown | ribosome biogenesis | nucleolus | YIL105C YMR236W YOR299W YMR116C YLR427W YDR225W YOR080W YIL035C YNL175C YDR386W YDL213C YPR110C YPL259C | KRRI-Interacting protein 1 | Krr1p binding protein | |
| KRR1 | YCL059C | molecular_function unknown | rRNA processing* | nucleolus | YNL132W YMR116C YLR197W YGR145W YDL148C YBL004W YDL014W YDR299W YJL109C YPL217C YMR128W YLR186W YHR148W YJR002W YLL011W YDR449C YMR093W YPR144C YGL201C YLR409C YDR324C YER127W YPL126W YPR137W YDL166C YKR060W YLR175W YBR247C YCR057C YDL213C YPL259C | Involved in cell division and spore germination | | Null mutant is inviable |
| KRS1 | YDR037W | lysine-tRNA ligase activity | lysyl-tRNA aminoacylation | cytoplasm | YDL126C YPR056W YJL124C YNL135C YDR388W YBR055C | lysyl-tRNA synthetase | lysine-tRNA ligase | Null mutant is inviable; mutants can show resistance to 5-methyltryptophan, 5-fluorotryptophan and c |
| KSP1 | YHR082C | protein serine/threonine kinase activity | protein amino acid phosphorylation | nucleus | YNL192W YJL095W YDR127W YNL201C YAL016W YML057W YKR024C YKL045W YHR186C | Serine/threonine kinase similar to casein kinase II and other serine/threonine protein kinases | | Null mutant is viable |
| KSS1 | YGR040W | MAP kinase activity | protein amino acid phosphorylation* | nucleus | YJR072C YGL245W YDR239C YPR115W YHR033W YLR362W YDL159W YPL049C YPR010C YML099C YKL104C YDR190C YGL008C YMR319C YHR200W YDL097C YKR048C YIL142W YMR290C YGR155W YGL062W YGL178W YLL039C YER167W YOL078W YER093C YHR084W YLR304C YLR154C YDR343C YML123C YN | Recovery from alpha factor arrest | MAP kinase|involved in pheromone signal transduction | |
| KTR1 | YOR099W | alpha-1,2-mannosyltransferase activity | O-linked glycosylation* | Golgi apparatus | | mannosyltransferase involved in O- and N-linked glycosylation | type II transmembrane protein | Null mutant is viable |
| KTR2 | YKR061W | mannosyltransferase activity | N-linked glycosylation* | Golgi apparatus | | May be involved in extracellular matrix assembly; involved in N-linked glycosylation of cell wall ma | mannosyltransferase (putative)|type 2 membrane protein | Null mutant is viable, with partial resistance to killer toxin |
| KTR3 | YBR205W | mannosyltransferase activity | cell wall organization and biogenesis* | membrane fraction | YLR338W YMR060C YDR170C YBR017C YML115C YGL212W YHR105W YFL038C YPR107C YDL101C | Putative alpha-1,2-mannosyltransferase | alpha-1,2-mannosyltransferase (putative) | |
| KTR4 | YBR199W | mannosyltransferase activity | N-linked glycosylation | Golgi apparatus | | Putative alpha-1,2-mannosyltransferase | alpha-1,2-mannosyltransferase (putative) | |
| KTR5 | YNL029C | mannosyltransferase activity | cell wall organization and biogenesis* | Golgi apparatus | YPR041W | Putative mannosyltransferase of the KRE2 family | mannosyltransferase (putative) | Null mutant is viable |
| KTR6 | YPL053C | mannosylphosphate transferase activity | cell wall organization and biogenesis* | membrane fraction | YER022W YGL181W | Similar to KRE2, mannosylphosphate transferase which may recognize any oligosaccharides with at leas | mannosylphosphate transferase | Null mutant is viable, hypersensitive to Calcofluor White and hygromycin B; shows less binding to Al |